Key result
Carriers of the SUR1 exon 18 Thr759 T allele had 12.8% lower fasting C-peptide and 12.4% lower acute C-peptide responses compared to noncarriers.
Why the study?
Do SUR1 gene sequence variants reduce insulin secretion parameters in nondiabetic subjects?
Cross-Sectional (n=731)
Do SUR1 gene sequence variants reduce insulin secretion parameters in nondiabetic subjects?
Sequence variants in the SUR1 gene are associated with lower insulin secretion parameters in nondiabetic individuals, particularly in female and overweight subjects.
Answers are grounded in this paper and cite their sources.
Should not change practice in nondiabetics; leaves open SUR1 variant effects on diabetes risk.
The high-affinity sulfonylurea receptor 1 (SUR1) plays an important role in regulating insulin secretion. In the Québec Family Study, we genotyped 731 individuals (685 nondiabetic [ND] subjects) for the SUR1 gene IVS15-3c-->t and exon 18 Thr759(ACC-->ACT) polymorphisms using polymerase chain reaction-restriction fragment-length polymorphism analysis. Phenotypes measured were fasting plasma glucose (GLU), fasting plasma insulin (INS), and fasting C-peptide (CPEP), as well as oral glucose tolerance test (OGTT) responses; they were adjusted for age, sex, waist circumference, and the sum of six skinfold thicknesses. In ND subjects, exon 18 Thr759(ACC-->ACT) T allele carriers (T+) had lower CPEP (P = 0.022, -12.8%) and acute C-peptide responses (area above basal in first 30 min [CP30]) (P = 0.051, -12.4%) than noncarriers (T-). Also, in those with the cT/tC haplotype (from both IVS15-3c-->t and exon 18 Thr759[ACC-->ACT] polymorphisms), CPEP (P = 0.005, -21.2%), CP30 (P = 0.034, -19.2%), and total C-peptide responses (P = 0.016, -20.2%) were lower than that in cT- subjects. In overweight individuals (BMI >25 kg/m2), differences between carriers and noncarriers of the T or cT alleles were greater for GLU (P = 0.023-0.034), CPEP (P = 0.021-0.015), acute OGTT insulin response (P = 0.014-0.019), and CP30 (P = 0.034-0.019). These results suggest that the T and cT allele variants are associated with lower insulin secretion parameters, particularly in female and overweight subjects, adding evidence to the role of SUR1 sequence variants in decreased insulin secretion.
No takes yet. Share an insight, caveat, or question.
Weisnagel et al. (2001) conducted a cross-sectional in Nondiabetic (n=731). SUR1 gene exon 18 Thr759 T allele and cT/tC haplotype vs. Noncarriers was evaluated on Fasting C-peptide (CPEP) (-12.8% difference, p=0.022). Carriers of the SUR1 exon 18 Thr759 T allele had 12.8% lower fasting C-peptide and 12.4% lower acute C-peptide responses compared to noncarriers.
Synapse has enriched 10 related papers. Consider them for comparative context: